- Home
- Publications
- Publication Search
- Publication Details
Title
Tenofovir Alafenamide
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 50, Issue 11, Pages 942-952
Publisher
SAGE Publications
Online
2016-07-28
DOI
10.1177/1060028016660812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment
- (2016) Anton Pozniak et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Brief Report
- (2016) David Wohl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
- (2016) Anthony Mills et al. LANCET INFECTIOUS DISEASES
- Characterization of HIV-1 Resistance to Tenofovir AlafenamideIn Vitro
- (2015) Nicolas A. Margot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
- (2015) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity
- (2014) Rujuta A Bam et al. ANTIVIRAL THERAPY
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
- (2014) M. Markowitz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
- (2011) Andrew M. Hall et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Unknown
- (2008) G. Birkus et al. MOLECULAR PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started